The central disturbance affects both the initiation of movement and the regulation of behavior. Depending on how these systems are expressed, a person may show markedly reduced activity, mutism, posturing, or resistance to instructions, while another episode may involve repetitive movements or intense agitation. This range makes careful behavioral observation essential for recognizing the syndrome accurately.
Catatonia is not limited to one diagnostic category. It may accompany mood disorders, psychotic disorders, neurological conditions, medical illnesses, or medication effects. This broad association means that identifying catatonic signs is only part of the clinical task. The assessment must also investigate the underlying condition or exposure that may be contributing to the presentation.
Clinicians look for changes across movement, speech, responsiveness, and behavior rather than relying on a single sign. Stupor and mutism indicate markedly reduced engagement, whereas posturing, negativism, and repetitive movements reveal other patterns of motor or behavioral disturbance. Intense agitation can also occur, so observation should account for both inhibited and highly activated states.
Assessment begins with careful observation of movement, behavior, responsiveness, speech, and recurring patterns such as posturing or negativism. Clinicians then evaluate possible underlying causes, including psychiatric disorders, neurological or medical conditions, and medication effects. This combined approach supports prompt recognition while helping determine which broader condition may require attention alongside the catatonic symptoms.
Lorazepam, a benzodiazepine, is commonly used as an initial treatment for catatonia. Its place in management reflects the need to address the syndrome promptly after recognition, while clinicians continue evaluating associated psychiatric, neurological, medical, or medication-related causes. The source material identifies benzodiazepine treatment as common, but does not specify dosing or response criteria.
Electroconvulsive therapy may be considered when catatonic symptoms are severe, persist over time, or do not respond sufficiently to initial treatment. It therefore serves as an important treatment option when benzodiazepine therapy does not provide an adequate outcome. The decision is tied to symptom severity and treatment response rather than to a single underlying diagnosis.